Furthermore, their genetic risk analysis for SLC5A2 variants showed decreased HF risk for each additional allele inherited, with a more pronounced effect in patients without T2DM or coronary artery disease. This evidence concerns the gene SLC5A2 and type 2 diabetes mellitus.